Synergy between In situ Cryoablation and TLR9 Stimulation Results in a Highly Effective In vivo Dendritic Cell Vaccine
- 15 July 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (14), 7285-7292
- https://doi.org/10.1158/0008-5472.can-06-0206
Abstract
Dendritic cells (DC) are professional antigen-presenting cells that play a pivotal role in the induction of immunity. Ex vivo–generated, tumor antigen–loaded mature DC are currently exploited as cancer vaccines in clinical studies. However, antigen loading and maturation of DC directly in vivo would greatly facilitate the application of DC-based vaccines. We have previously shown that in situ tumor destruction by ablative treatments efficiently delivers antigens for the in vivo induction of antitumor immunity. In this article, we show that although 20% of the draining lymph node DCs acquire intratumorally injected model antigens after in situ cryoablation, only partial protection against a subsequent tumor rechallenge is observed. However, we also show that a combination treatment of cryoablation plus TLR9 stimulation via CpG-oligodeoxynucleotides is far more effective in the eradication of local and systemic tumors than either treatment modality alone. Analysis of the underlying mechanism revealed that in situ tumor ablation synergizes with TLR9 stimulation to induce DC maturation and efficient cross-presentation in tumor-bearing mice, leading to superior DC function in vivo. Therefore, in situ tumor destruction in combination with CpG-oligodeoxynucleotide administration creates a unique “in situ DC vaccine” that is readily applicable in the clinic. (Cancer Res 2006; 66(14): 7285-92)Keywords
This publication has 52 references indexed in Scilit:
- Toll-like receptor 2 controls expansion and function of regulatory T cellsJCI Insight, 2006
- Activation of dendritic cells by local ablation of hepatocellular carcinomaJournal of Hepatology, 2005
- Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cellsNature Immunology, 2005
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- Toll-like receptor signallingNature Reviews Immunology, 2004
- Molecular identification of a danger signal that alerts the immune system to dying cellsNature, 2003
- Interstitial ablative techniques for hepatic tumoursBritish Journal of Surgery, 2003
- CpG Motifs in Bacterial DNA and Their Immune EffectsAnnual Review of Immunology, 2002
- Long-term results of treating hepatic colorectal metastases with cryosurgeryBritish Journal of Surgery, 2001
- A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injectionInternational Journal of Cancer, 2001